Cargando…

Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020

Biomarkers can guide precision medicine in clinical trials and practice. They can increase clinical trials' efficiency through selection of study populations more likely to benefit from treatment, thus increasing statistical power and reducing sample size requirements or study duration. We perf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakker, Elisabeth, Starokozhko, Viktoriia, Kraaijvanger, Jet W. M., Heerspink, Hiddo J. L., Mol, Peter G. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651650/ https://www.ncbi.nlm.nih.gov/pubmed/37853917 http://dx.doi.org/10.1111/cts.13641

Ejemplares similares

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making
por: Bakker, Elisabeth, et al.
Publicado: (2022)

Biomarker Qualification at the European Medicines Agency: A Review of Biomarker Qualification Procedures From 2008 to 2020
por: Bakker, Elisabeth, et al.
Publicado: (2022)

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations
por: Mol, Peter G. M., et al.
Publicado: (2018)

Attention for sex in COVID-19 trials: a review of regulatory dossiers
por: de Vries, Sieta T, et al.
Publicado: (2022)

Treating diabetic complications; from large randomized clinical trials to precision medicine
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Precision medicine approaches for diabetic kidney disease: opportunities and challenges
por: Tye, Sok Cin, et al.
Publicado: (2021)

Erratum to: Precision medicine approaches for diabetic kidney disease: opportunities and challenges
por: Tye, Sok Cin, et al.
Publicado: (2022)

Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
por: Jonker, Carla J., et al.
Publicado: (2022)

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe
por: Kallio, Marko J., et al.
Publicado: (2022)

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe
por: Koomen, Jeroen V., et al.
Publicado: (2021)

Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy
por: de Zeeuw, Dick, et al.
Publicado: (2020)

Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days
por: Starokozhko, Viktoriia, et al.
Publicado: (2016)

Rat precision-cut liver slices predict drug-induced cholestatic injury
por: Starokozhko, Viktoriia, et al.
Publicado: (2017)

Public health measures during the COVID-19 pandemic through the lens of community organisations and networks in the Netherlands (2020–2021): five lessons for pandemic decision-making
por: Kolner, Carla, et al.
Publicado: (2022)

Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
por: Bakker, Elisabeth, et al.
Publicado: (2021)

HIV estimates through 2018: data for decision-making
por: Mahy, Mary, et al.
Publicado: (2019)

Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney
por: Heerspink, Hiddo J L
Publicado: (2019)

Public Health Ethics and ‘the Science’ in Public Decision-Making
por: Coggon, J
Publicado: (2022)

Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Data-driven decision-making for precision diagnosis of digestive diseases
por: Jiang, Song, et al.
Publicado: (2023)

Access to Chemical Data Used in Regulatory Decision Making
por: Goldman, Lynn R., et al.
Publicado: (2013)

The Use of External Controls in FDA Regulatory Decision Making
por: Jahanshahi, Mahta, et al.
Publicado: (2021)

The Role of European Schools and University Departments of Public Health in the 2020 COVID-19 Response, European Region, 2020
por: Bauernfeind, Ariane, et al.
Publicado: (2021)

Management Accounting in Public Service Decision Making
por: Prowle, Malcolm
Publicado: (2020)

Fuzzy Decision Making in Public Health Strategies
por: Massad, Eduardo, et al.
Publicado: (2008)

Decision-making process for introduction of maternal vaccines in Kenya, 2017–2018
por: Otieno, Nancy A., et al.
Publicado: (2021)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
por: Vart, Priya, et al.
Publicado: (2022)

The Die Is Cast: Precision Electrophilic Modifications Contribute to Cellular Decision Making
por: Long, Marcus J. C., et al.
Publicado: (2016)

Navigating the uncertainty of precision cancer screening: The role of shared decision-making
por: Gallagher, Joseph H., et al.
Publicado: (2023)

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders
por: Jonker, Carla J., et al.
Publicado: (2021)

Economic Evaluation Enhances Public Health Decision Making
por: Rabarison, Kristina M., et al.
Publicado: (2015)

COVID-19 serosurveys for public health decision making
por: Murhekar, Manoj V, et al.
Publicado: (2021)

COVID-19 and the scaled-down 2020 Hajj Pilgrimage—Decisive, logical and prudent decision making by Saudi authorities overcomes pre-Hajj public health concerns
por: Zumla, Alimuddin, et al.
Publicado: (2020)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
por: Van Raalte, Daniel H., et al.
Publicado: (2022)

Analytical decision-making methods for evaluating sustainable transport in European corridors
por: Lami, Isabella
Publicado: (2014)

Responsible decision-making for plant research and breeding innovations in the European Union
por: Eriksson, Dennis, et al.
Publicado: (2017)

Molecular-based precision oncology clinical decision making augmented by artificial intelligence
por: Zeng, Jia, et al.
Publicado: (2021)

Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making
por: Chow, Ngai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kgtp8b80nobjrgcuckfbp2sb0c